Author:
Tan Sin Yee,Khan Rahela Ambaras,Khalid Khairil Erwan,Chong Chun Wie,Bakhtiar Athirah
Abstract
AbstractInappropriate use of antibiotics has been shown to contribute to the occurrence of multidrug-resistant organisms (MROs). A surveillance study was performed in the largest tertiary care hospital in Kuala Lumpur, Malaysia, from 2018 to 2020 to observe the trends of broad-spectrum antibiotics (beta-lactam/beta-lactamases inhibitors (BL/BLI), extended-spectrum cephalosporins (ESC), and fluoroquinolones (FQ)) and antibiotics against MRO (carbapenems, polymyxins, and glycopeptides) usage and the correlation between antibiotic consumption and MROs. The correlation between 3-year trends of antibiotic consumption (defined daily dose (DDD)/100 admissions) with MRO infection cases (per 100 admissions) was determined using a Jonckheere-Terpstra test and a Pearson’s Correlation coefficient. The antimicrobial resistance trend demonstrated a positive correlation between ESC and FQ towards the development of methicillin-resistant Staphylococcus aureus (MRSA), extended-spectrum beta-lactamase (ESBL)-producing Klebsiella spp, ESBL-producing Escherichia coli (E. coli), and MRO Acinetobacter baumannii (A. baumannii). Increasing carbapenem consumption was positively correlated with the occurrence of ESBL-producing Klebsiella spp and E. coli. Polymyxin use was positively correlated with ESBL-producing Klebsiella spp, MRO A. baumannii, and carbapenem-resistant Enterobacteriaceae. The findings reinforced concerns regarding the association between MRO development, especially with a surge in ESC and FQ consumption. Stricter use of antimicrobials is thus crucial to minimise the risk of emerging resistant organisms.
Publisher
Springer Science and Business Media LLC
Reference36 articles.
1. Gould, I. M. & Bal, A. M. New antibiotic agents in the pipeline and how they can help overcome microbial resistance. Virulence 4(2), 185–191 (2013).
2. World Health Organization. Global Antimicrobial Resistance Surveillance System (GLASS) Report: Early Implementation 2017–2018. (World Health Organization, 2018).
3. Meyer, E., Gastmeier, P., Deja, M. & Schwab, F. Antibiotic consumption and resistance: data from Europe and Germany. Int. J. Med. Microbiol. 303, 388–395 (2013).
4. Dhingra, S. et al. Microbial resistance movements: an overview of global public health threats posed by antimicrobial resistance, and how best to counter. Front. Publ. Health 8, 535668 (2020).
5. Chandy, S. J. et al. High cost of burden and health consequences of antibiotic resistance: the price to pay. J. Infect. Dev. Ctries. 8(9), 1096–1102 (2014).
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献